Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$9.93 - $10.09 $40,484 - $41,136
4,077 Added 5.79%
74,547 $752,000
Q3 2022

Nov 14, 2022

BUY
$0.11 - $9.94 $7,751 - $700,471
70,470 New
70,470 $698,000
Q2 2022

Aug 15, 2022

SELL
$9.77 - $9.84 $203,899 - $205,360
-20,870 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$9.69 - $9.81 $100,184 - $101,425
-10,339 Reduced 33.13%
20,870 $205,000
Q4 2021

Feb 14, 2022

BUY
$9.68 - $9.77 $302,103 - $304,911
31,209 New
31,209 $303,000

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About IBERE PHARMACEUTICALS


  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.